Log In
BCIQ
Print this Print this
 

RLBN3012

  Manage Alerts
Collapse Summary General Information
Company Relburn-Metabolomics Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHyperuricemia / gout
Indication DetailsTreat chronic gout
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today